Evidence map›Paper›PMID 38234133›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2024

Isolation, structure modification, and anti-rheumatoid arthritis activity of isopimarane-type diterpenoids from

Yong-Xin Luo, Xu Gong, Zhi-Cheng Su, Jin-Feng Mo, Dong-Li Li, Ri-Hui Wu, Jing-Wei Jin, Ming Lang, Jin-Ping Wang, Xue-Tao Xu and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Frontiers in pharmacology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yong-Xin LuoSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.
Xu GongSchool of Pharmacy and Food Engineering, International Healthcare Innovation Institute, Wuyi University, Jiangmen, People's Republic of China.
Zhi-Cheng SuSchool of Pharmacy and Food Engineering, International Healthcare Innovation Institute, Wuyi University, Jiangmen, People's Republic of China.
Jin-Feng MoSchool of Pharmacy and Food Engineering, International Healthcare Innovation Institute, Wuyi University, Jiangmen, People's Republic of China.
Dong-Li LiSchool of Pharmacy and Food Engineering, International Healthcare Innovation Institute, Wuyi University, Jiangmen, People's Republic of China.
Ri-Hui WuSchool of Pharmacy and Food Engineering, International Healthcare Innovation Institute, Wuyi University, Jiangmen, People's Republic of China.
Jing-Wei JinSchool of Pharmacy and Food Engineering, International Healthcare Innovation Institute, Wuyi University, Jiangmen, People's Republic of China.
Ming LangSchool of Pharmacy and Food Engineering, International Healthcare Innovation Institute, Wuyi University, Jiangmen, People's Republic of China.
Jin-Ping WangDepartment of Pharmacy, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, People's Republic of China.
Xue-Tao XuSchool of Pharmacy and Food Engineering, International Healthcare Innovation Institute, Wuyi University, Jiangmen, People's Republic of China.
Li-She GanSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.
Wuyi University · CNShenzhen Second People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Arthritis, RheumatoidDiterpenesOrthosiphonAbietanesHumansNF-kappa BTumor Necrosis Factor-alphaAbietanesDiterpenesNF-kappa BTumor Necrosis Factor-alphaIsopimarane diterpenoidMH7AOrthosiphon aristatus; anti-rheumatoid arthritisstructure modification

Identifiers

PMID38234133
PMCPMC10798283
OpenAlexW4390984234

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.